{"id":"NCT00236197","sponsor":"Eisai Inc.","briefTitle":"E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers","officialTitle":"E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":"2006-03","completion":"2008-06","firstPosted":"2005-10-12","resultsPosted":"2009-11-05","lastUpdate":"2009-11-11"},"enrollment":619,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heartburn"],"interventions":[{"type":"DRUG","name":"rabeprazole sodium","otherNames":["Aciphex"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate the safety and efficacy of rabeprazole 10 mg in treating frequent heartburn.","primaryOutcome":{"measure":"Complete Heartburn Relief During the First Full 24-Hour Period in Intent-to-Treat (ITT) Population","timeFrame":"First 24 hours","effectByArm":[{"arm":"Placebo","deltaMin":100,"sd":null},{"arm":"Rabeprazole 10 mg","deltaMin":121,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":312},"commonTop":["Upper respiratory tract infection"]}}